The health care related economic burden due to female genital mutilation (FGM) is estimated to be US$1.4 billion per year. This number will continue to rise unless efforts are accelerated to prevent the harmful practice, to reduce the harm to women and
girls, and to minimise the health burden and associated health care costs to already strained health systems.
Key Addresses
- Dr Tedros Adhanom Ghebreyesus, Director-General, WHO
- the Rt Hon Amanda Milling MP, Minister for Asia, FCDO, U.K.
- Dr Soumya Swaminathan, Chief Scientist, WHO
“Economic burden of female genital mutilation in 27 high-prevalence countries”
A study by the World Health Organization in collaboration with Triangulate Health Ltd, published in BMJ Global Health StudyOverview by Mr David Tordrup, Triangulate Health Ltd, and Dr Christina Pallitto, WHO/HRP
Panel discussion with key stakeholders and experts working to end FGM
Ms Edna Adan - Founder of Edna Adan Hospital, University, and Foundation, Somaliland
Her Excellency Maya Morsy - President of the National Council on Women, Egypt
Mr Robert Kasenene - FGM Policy and Advocacy Specialist, African Union Commission
Dr Houleymatou Diallo - National Coordinator of MCH Programme, Ministry of Health, Guinea
Mr Amjad Alhaj - Medical Students International Network, Sudan
Dr Paul Fife - Director of Department for Human Development, NORAD, Norway
Professor Charlotte Watts - Chief Scientific Adviser and Director for Research and Evidence,FCDO, U.K.
Webinar in English with live interpretation into Arabic and French